Skip to main navigation Skip to search Skip to main content

δ-Opioid receptor antagonist inhibits immunomodulation by met- enkephalin analogs

  • Vijay K. Singh*
  • , Kirti Bajpai
  • , Prem Narayan
  • , Virendra S. Yadav
  • , Vikas C. Dhawan
  • , Wahajul Haq
  • , Krishna B. Mathur
  • , Shyam S. Agarwal
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

The methionine-enkephalin (Met-enkephalin, Tyr-Gly-Gly-Phe-Met) analogs Tyr-D-Ala-Gly-MePhe-Met NHC3H7-iso (1) and Tyr-D-Ala-Gly-MePhe-Gly- NHC3H7-iso (2) have been shown to enhance human T cell proliferation in in vitro treatment. Their immunomodulatory activities were completely blocked by naloxone, an opioid antagonist. Now we demonstrate that a selective δ-opioid receptor antagonist, ICI-174,864, completely blocks enhancement of T cell proliferation by analogs (1) and (2). The T cell-stimulatory effect was only partially inhibited by the μ-receptor-selective antagonist, β- funaltrexamine hydrochloride. The κ-opioid receptor antagonist, nor- binaltorphimine dihydrochloride, showed no effect on T cell-proliferation stimulated by analogs (1) and (2). These observations suggest that analogs (1) and (2) of Met-enkephalin stimulate T cell proliferation predominantly via δ-opioid receptor present on T cells.

Original languageEnglish
Pages (from-to)355-360
Number of pages6
JournalNeuroImmunoModulation
Volume6
Issue number5
DOIs
StatePublished - Aug 1999

Keywords

  • Analogs
  • Antagonist
  • Enkephalin
  • Immunomodulator
  • T cell proliferation

Fingerprint

Dive into the research topics of 'δ-Opioid receptor antagonist inhibits immunomodulation by met- enkephalin analogs'. Together they form a unique fingerprint.

Cite this